Concert Pharmaceuticals Inc
NASDAQ:CNCE
Net Margin
Concert Pharmaceuticals Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | US |
| Market Cap | 401.2m USD |
| Net Margin |
-390 564%
|
| Country | US |
| Market Cap | 277.3B USD |
| Net Margin |
11%
|
| Country | US |
| Market Cap | 164.1B USD |
| Net Margin |
13%
|
| Country | US |
| Market Cap | 118B USD |
| Net Margin |
39%
|
| Country | US |
| Market Cap | 108.5B USD |
| Net Margin |
29%
|
| Country | AU |
| Market Cap | 135.7B AUD |
| Net Margin |
17%
|
| Country | US |
| Market Cap | 81.8B USD |
| Net Margin |
2%
|
| Country | US |
| Market Cap | 63.8B USD |
| Net Margin |
-116%
|
| Country | US |
| Market Cap | 43.1B USD |
| Net Margin |
-33%
|
| Country | US |
| Market Cap | 31.7B USD |
| Net Margin |
12%
|
| Country | KR |
| Market Cap | 37.3T KRW |
| Net Margin |
17%
|
Profitability Report
View the profitability report to see the full profitability analysis for Concert Pharmaceuticals Inc.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Concert Pharmaceuticals Inc's most recent financial statements, the company has Net Margin of -390 564.3%.
You don't have any saved screeners yet
